US Patent Issued to ARCUTIS BIOTHERAPEUTICS on Nov. 4 for "Pharmaceutical compositions of spironolactone for deep dermal drug delivery" (Colorado, California Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,652, issued on Nov. 4, was assigned to ARCUTIS BIOTHERAPEUTICS INC. (Westlake Village, Calif.).

"Pharmaceutical compositions of spironolactone for deep dermal drug delivery" was invented by David W. Osborne (Fort Collins, Colo.) and Babak N. Tofig (Westlake Village, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions for the topical administration of spironolactone to the pilosebaceous unit and methods for administering the same. The pharmaceutical compositions comprise aqueous suspensions of submicron particles of spironolactone in water."

The patent was filed on Nov. 10, 2022, under Application No. 17/984,405.

*For f...